Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials-Reference-Cited by-同舟云学术

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

Published:2008-06-10 Issue:1 Volume:99 Page:51-56
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Ceresoli G L,Castagneto B,Zucali P A,Favaretto A,Mencoboni M,Grossi F,Cortinovis D,Conte G Del,Ceribelli A,Bearz A,Salamina S,De Vincenzo F,Cappuzzo F,Marangolo M,Torri V,Santoro A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6604442.pdf

Reference38 articles.

1. Agresti A (1992) A survey of exact inference for contingency tables. Stat Sci 7: 131–177

2. Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15: 257–260

3. Castagneto B, Botta M, Aitini E, Spigno F, Degiovanni D, Alabiso O, Serra M, Muzio A, Carbone R, Buosi R, Galbusera V, Piccolini E, Giaretto L, Rebella L, Mencoboni M (2008) Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Ann Oncol 19: 370–373

4. Ceresoli GL, Chiti A, Zucali PA, Cappuzzo F, De Vincenzo F, Cavina R, Rodari M, Poretti D, Lutman FR, Santoro A (2007a) Assessment of tumor response in malignant pleural mesothelioma. Cancer Treat Rev 33: 533–541

5. Ceresoli GL, Gridelli C, Santoro A (2007b) Multidisciplinary treatment of malignant pleural mesothelioma. Oncologist 12: 850–863

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy in Mesotheliomas: Uphill All the Way;Cancers;2024-05-22

2. Prise en charge diagnostique et thérapeutique du mésothéliome pleural en 2023;Revue des Maladies Respiratoires Actualités;2023-10

3. One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy;International Journal of Molecular Sciences;2023-03-28

4. Pleural Mesothelioma in the Era of Immunotherapy;Clinical Medicine Insights: Oncology;2023-01

5. Surgical Management of Malignant Pleural Mesothelioma: From the Past to the Future;Mesothelioma - Diagnostics, Treatment and Basic Research;2022-12-21